Oppenheimer & Co. Inc. Sells 560 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Oppenheimer & Co. Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,785 shares of the medical equipment provider’s stock after selling 560 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Intuitive Surgical were worth $9,283,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Massachusetts Financial Services Co. MA acquired a new position in Intuitive Surgical in the 3rd quarter worth about $558,807,000. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB increased its stake in shares of Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Strategic Financial Concepts LLC increased its stake in shares of Intuitive Surgical by 50,740.8% in the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after buying an additional 312,056 shares during the period. Finally, State Street Corp raised its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.0 %

Shares of NASDAQ ISRG opened at $563.77 on Friday. The firm has a market capitalization of $200.80 billion, a P/E ratio of 87.95, a P/E/G ratio of 5.85 and a beta of 1.39. The firm’s 50-day moving average price is $568.89 and its 200-day moving average price is $527.90. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Raymond James increased their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Truist Financial upped their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,077 shares of company stock valued at $4,620,025 in the last three months. Corporate insiders own 0.80% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.